other factor which has forced FDA to change course has been congressional pressure which was seen when new obesity drugs were approved dementia is also huge problem and given the right advocacy approval mechanisms can be facilitated, patient groups have mostly played crucial role in new drug advisory committee meetings
- Forums
- ASX - By Stock
- FDA Official statement Urges Drug Developers to Focus on Data
other factor which has forced FDA to change course has been...
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $2.401K | 800.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
77 | 110142186 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 150940914 | 62 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
73 | 107892186 | 0.002 |
26 | 140640147 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 150940914 | 62 |
0.005 | 8746584 | 15 |
0.006 | 19463867 | 16 |
0.007 | 52264874 | 24 |
0.008 | 38120994 | 29 |
Last trade - 10.20am 08/11/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online